Jakub Woyciechowski

SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

M. Mikuła, J. Ostrowski, A. Wróbel, 2017, Oncotarget.

Discovery of a Series of Ester-substituted NLRP3 Inflammasome Inhibitors.

C. Gabel, R. Porter, J. Doedens, 2020, Bioorganic & medicinal chemistry letters.